LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Researchers Seeking Patients for Meniscus Clinical Study
Large Joints and Extremities

Researchers Seeking Patients for Meniscus Clinical Study

December 2, 2021 2 min read Premium comments

Advertisement

Secondary#kneemobility#kneepain#meniscusprosthesis

ATRO Medical is seeking study participants to test a new procedure to place a meniscus prosthesis after the native one has been removed.

The study is being conducted at the orthopedic departments of Sint Maartenskliniek, the MUMC+ and Haaglanden Medical Center in The Netherlands. The researchers are investigating whether the reconstruction of the mensicus with this prosthesis improves pain relief and improvement of the knee mobility. They hope to enroll 10 patients.

The new TRAMMPOLIN meniscus prosthesis by ATRO Medical is made of medical grade plastic and provides shock absorbance as the knee bends and moves. The new implant will be placed via arthroscopy.

Eligibility criteria includes being between the ages of 18 and 70 and having a total or partially removed medial meniscus. After the implantation of the meniscus prosthesis the study participants will be monitored for two years.

Dr. Tony van Tienen said that the initial attempt at transplanting a meniscus prosthesis in 2019 did not go as planned. He said, “We saw too little function improvement with the first patients: The knee remained stiff after the implantation. Unfortunately, we had to remove a few meniscus prostheses.”

He added, “The good news is that we didn’t observe any further damages on the medial side of the knee. These patients have continued their usual care trajectory. But the initial complaints were still there. Therefore, the solution we would have liked to offer had not yet been realized.”

The Dutch Arthritis Society was one the first groups to initiate research on meniscus transplantation almost a decade ago. Most the preclinical research was conducted at the Radboud University Medical Center, where Dr. Van Tienen did much of the supervising.

Both he and Dr. Jan Hunik founded the startup ATRO Medical to bring the TRAMMPOLIN meniscus prostheses to market.

Advertisement

CEO Jan Hunik said, “As a startup, we have the opportunity to make a difference for many patients. In Europe, more than 400,000 patients with persistent knee pain after meniscus removal are waiting for a surgical solution that can reduce their pain. But first, we need to prove in small studies that the prostheses provides long-lasting pain relief. After the previous study, the design was changed and we have tested our meniscus prostheses even more extensively than before. The prostheses meet all the requirements. But actual function improvement it gives to a real patient will only become clear in practice.”

If you have patients interested in participating in the AIR2 study, they can find out more information at the ATRO Medical website or through the three participating clinics.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy